drug
as of 2026-07-01ALK3831
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alkermes, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
NCT02634346Phase 3Completed
KOLs & investigators
1
David McDonnell, MDKOL score 8
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here